Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year.
The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March 31, 2022, for a bottom-line gain of 100% and sales growth of 14% compared with Q1 2021.
“We saw a strong start to the year and our first-quarter results demonstrate the continued strength of our innovative product portfolio and commercial execution,” Alcon CEO David Endicott said in a news release. … “While we are pleased with these results, we continue to expect broader headwinds, including inflation and foreign exchange pressures, to persist.”
Adjusted to exclude one-time items, earnings per share were $0.68, $0.16 ahead of the Street, where analysts were looking for EPS of $0.52 on sales of $2.1 billion.
Alcon said it still expects to log adjusted EPS of $2.35 to $2.45 this year on sales of $8.7 to $8.9 billion.
Investors reacted by sending ALC shares up 4% to $65.29 in after-hours trading.